Welcome to LookChem.com Sign In|Join Free
  • or
3(2H)-Pyridazinone, 6-[3-bromo-4-(4-morpholinyl)phenyl]-4,5-dihydro- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

84313-88-2

Post Buying Request

84313-88-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

84313-88-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 84313-88-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,3,1 and 3 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 84313-88:
(7*8)+(6*4)+(5*3)+(4*1)+(3*3)+(2*8)+(1*8)=132
132 % 10 = 2
So 84313-88-2 is a valid CAS Registry Number.

84313-88-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(3-bromo-4-morpholin-4-ylphenyl)-4,5-dihydro-1H-pyridazin-6-one

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:84313-88-2 SDS

84313-88-2Downstream Products

84313-88-2Relevant academic research and scientific papers

6-(4-Morpholino-phenyl)-4,5-dihydro-2H-pyridazine-3-ones: potent platelet aggregation inhibitors and antithrombotics

Goeschke, R,Gainer, J,Howarth, GA,Wallis, RB,Kerry, R,et al.

, p. 715 - 721 (2007/10/02)

A series of di- and tri-substituted 6-phenyl-4,5-dihydro-2H-pyridazine-3-ones is described.The compounds were designed to be antithrombotics and were assessed for their inhibitory properties on platelet aggregation and on thrombus formation in an arteriov

Method of treating thrombotic disease with pyridazinones

-

, (2008/06/13)

The invention concerns compounds of formula I STR1 wherein R is a fluorine, bromine or iodine atom or the amino, acetylamino, methyl, cyano, hydroxyl, methoxy or trifluoromethyl group, the tautomeric forms thereof, and acid addition salts of the compounds

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 84313-88-2